AZITHROMYCIN DECREASE SALIVA CALPROTECTIN IN PATIENTS WITH PERIODONTAL DISEASES.

Journal Title: Journal of IMAB - Annual Proceeding (Scientific Papers) - Year 2014, Vol 20, Issue 1

Abstract

 Objective: Calprotectin is a calcium binding heterocomplex protein which appear to have regulatory functions in the inflammatory process. Epithelial cells which expressing calprotectin are more resistant to bacterial invasion . In acute phase inflammatory reactions calprotectin is detectable in elevated levels. The aim of the present study is to detect the calprotectin level in saliva in patients with periodontal disease (chronic and aggressive periodontitis and gingivitis) and to follow calprotectin level during azithromycin treatment. Methods and materials: In nine healthy patients without systemic disease and malignancy whole unstimulated saliva was investigated. Salivary calprotectin levels were measured by enzyme-linked-immunosorbent using a commercial kit (ELISA Hycult Biotech). Azithromycin treatment was taken as 500 mg (2 x 250 mg tabls.) once daily at 10.00 am for 4 consecutive days. Results: At baseline Day levels of calprotectin ranged between 1.45 and 2.97; median 2.19. On Day 5 (first day after azithromycin treatment) the salivary calprotectin levels decreased in 6 of the patients. The measured values at Day 10 were more similar to those at Day 5, than those at Day zero. This was confirmed by the values of the average median of calprotectin. Conclusion: We present the first study with the application of antibiotic and measurement the calprotectin levels before, during and after azithromycin intake with no side effects reported. Measuring calprotectin levels could benefit the monitoring of antibiotic treatment efficacy in patients with gingivitis and periodontitis.

Authors and Affiliations

Vladimir Panov, Assya Krasteva, Adriana Krasteva, Aneta Ivanova, Anton Panov, Zahariy Krastev

Keywords

Related Articles

 HARMONIC SCALPEL POSSIBILITIES IN THE SURGICAL TREATMENT OF SECONDARY HYPERPARATHYROIDISM

The significant changes in coagulation status during chroniodialysis, performed in patients with secondary hyperparathyroidism require completion of meticulous surgical hemostasis in order to prevent active bleeding in...

SINUS FLOOR AUGMENTATION WITH BONE BLOCK GRAFTING AND SIMULTANEOUS IMPLANT PLACEMENT

Placement of dental implants in the posterior maxillary edentulous areas is often compromised by the limited volume of bone due to the anatomy of the maxillary sinuses. In such cases, the technique of Sinus Lift is indic...

 ENDODONTICS AND THERMOVISION-TEMPERATURE CHANGES DURING PHOTO-ACTIVATED DISINFECTION IN ROOT CANALS. THERMOVISION DIAGNOSIS IN ENDODONTIC TREATMENT.

 Introduction: The application of thermovision in endodontics is an innovative method and has a great informative value, evidence proved, thanks to the use of last generation camera Flir A310 and software ThermaCam...

Research of periodontal status and treatment needs by CPITN in patients on haemodialysis and renal transplanted patients

The aim of the present study is to estimate the periodontal conditions and treatment needs by CPITN of 150 patients- 45 (30%) on haemodialysis, 45 (30%) renal transplanted patients and 60 (40%) healthy controls, age betw...

CLINICAL AND MICROBIOLOGICAL DATA IN PATIENTS WITH CHRONIC PERIODONTITIS.

Periodontitis is an infectious disease concerning supporting tissues of the teeth. The primary etiological agent for disease development and progression is the subgingival biofilm, but recently it is known that host fact...

Download PDF file
  • EP ID EP141765
  • DOI 10.5272/jimab.2014201.464
  • Views 57
  • Downloads 0

How To Cite

Vladimir Panov, Assya Krasteva, Adriana Krasteva, Aneta Ivanova, Anton Panov, Zahariy Krastev (2014).  AZITHROMYCIN DECREASE SALIVA CALPROTECTIN IN PATIENTS WITH PERIODONTAL DISEASES.. Journal of IMAB - Annual Proceeding (Scientific Papers), 20(1), 464-468. https://europub.co.uk/articles/-A-141765